UROV - Urovant Sciences Ltd
Previous close
16.24
0 0%
Share volume: 0
Last Updated: Fri 26 Mar 2021 05:00:00 AM CET
Medicinal and Botanical Manufacturing :
-0.98%
PREVIOUS CLOSE
CHG
CHG%
$16.24
0.00
0.00%
Summary score
65%
Profitability
75%
Dept financing
43%
Liquidity
51%
Performance
65%
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
182.58%
Return on assets
-71.16%
Return on sales
0%
Return on invested capital
233.05%
Total debt ratio
115.51%
Debt ratio change over timeo
-0.24%
Current Ratio
4.28%
Quick Ratio
0%
Cash Position Ratio
4.07%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
270.69%
Return on assets
-43.38%
Return on sales
0%
Return on invested capital
139.91%
Total debt ratio
181.74%
Debt ratio change over timeo
0.44%
Current Ratio
2.37%
Quick Ratio
0%
Cash Position Ratio
2.12%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
31.1%
Return on assets
-36.6%
Return on sales
0%
Return on invested capital
165.57%
Total debt ratio
223.61%
Debt ratio change over time
0.81%
Current Ratio
2.91%
Quick Ratio
0%
Cash Position Ratio
2.59%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-45.02%
Return on assets
-130.66%
Return on sales
0%
Return on invested capital
25.93%
Total debt ratio
-23.55%
Debt ratio change over time
-0.24%
Current Ratio
1.49%
Quick Ratio
0%
Cash Position Ratio
1.15%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | UROV | CVLB | CTXRW | OPNT |
|---|---|---|---|---|
| Return on equity | 182.58% | 0% | 0% | -6.85% |
| Return on assets | -71.16% | 0% | 0% | -5.01% |
| Return on sales | 0% | 0% | 0% | -92.08% |
| Return on invested capital | 233.05% | 0% | 0% | 9.77% |
| Profitability | 75% | 0% | 25% | 1% |
| Total debt ratio | 115.51% | 0% | 0% | 58.27% |
| Debt ratio change over time | -0.24% | 0% | 0% | 0.11% |
| Dept financing | 25% | 0% | 0% | 38% |
| Current Ratio | 2.37% | 0% | 0% | 7.74% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 2.12% | 0% | 0% | 6.31% |
| Liquididy | 75% | 0% | 0% | 46% |
| Short-term ratios | UROV | CVLB | CTXRW | OPNT |
|---|---|---|---|---|
| Return on equity | 270.69% | 0% | 0% | -0.84% |
| Return on assets | -43.38% | 0% | 0% | -1.09% |
| Return on sales | 0% | 0% | 0% | -11.43% |
| Return on invested capital | 139.91% | 0% | 0% | 10% |
| Profitability | 75% | 0% | 25% | 2% |
| Total debt ratio | 181.74% | 0% | 0% | 13.08% |
| Debt ratio change over time | 0.44% | 0% | 0% | -1.11% |
| Dept financing | 50% | 0% | 0% | 2% |
| Current Ratio | 2.37% | 0% | 0% | 7.74% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 2.12% | 0% | 0% | 6.31% |
| Liquididy | 41% | 0% | 0% | 50% |